# Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

> **NCT00125203** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 20 (—)

## Conditions studied

- Amyotrophic Lateral Sclerosis
- Sialorrhea

## Interventions

- **DRUG:** Botulinum toxin type B (Myobloc)
- **PROCEDURE:** Injection of salivary glands

## Key facts

- **NCT ID:** NCT00125203
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 20 (—)
- **Last updated:** 2012-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125203, "Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00125203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*